Title |
Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus
|
---|---|
Published in |
European Journal of Clinical Microbiology & Infectious Diseases, May 2011
|
DOI | 10.1007/s10096-011-1270-6 |
Pubmed ID | |
Authors |
M. Widerström, J. Wiström, A. Sjöstedt, T. Monsen |
Abstract |
Coagulase-negative staphylococci (CoNS), originally described as ubiquitous commensals of the healthy human skin and mucosa, have emerged as important opportunistic pathogens primarily causing healthcare-associated infections in patients with indwelling medical devices. Recent studies, utilizing new molecular typing methods, particularly on Staphylococcus epidermidis, have increased our understanding of the mechanisms that contribute to the evolutionary success of these extremely versatile microorganisms. In the following mini-review, we summarize recent research in this area focusing on the molecular methods and epidemiology of S. epidermidis and S. saprophyticus. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | <1% |
United Kingdom | 1 | <1% |
Denmark | 1 | <1% |
Sri Lanka | 1 | <1% |
Unknown | 171 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 31 | 18% |
Student > Master | 24 | 14% |
Researcher | 23 | 13% |
Student > Ph. D. Student | 22 | 13% |
Student > Postgraduate | 13 | 7% |
Other | 27 | 15% |
Unknown | 35 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 36 | 21% |
Medicine and Dentistry | 36 | 21% |
Immunology and Microbiology | 21 | 12% |
Biochemistry, Genetics and Molecular Biology | 18 | 10% |
Nursing and Health Professions | 5 | 3% |
Other | 20 | 11% |
Unknown | 39 | 22% |